Dora completed her PhD at Cambridge and brings experience in cancer research. Her work has influenced a number of articles in high- impact journals and she also led projects in industry-modelling cancer treatment response.
Blazar uses machine learning to predict cancer response to immunotherapy.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.